These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9499110)

  • 1. Application of a Fas ligand encoding a recombinant adenovirus vector for prolongation of transgene expression.
    Zhang HG; Bilbao G; Zhou T; Contreras JL; Gómez-Navarro J; Feng M; Saito I; Mountz JD; Curiel DT
    J Virol; 1998 Mar; 72(3):2483-90. PubMed ID: 9499110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of specific T-cell tolerance by adenovirus-transfected, Fas ligand-producing antigen presenting cells.
    Zhang HG; Liu D; Heike Y; Yang P; Wang Z; Wang X; Curiel DT; Zhou T; Mountz JD
    Nat Biotechnol; 1998 Nov; 16(11):1045-9. PubMed ID: 9831033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas-Fas ligand interactions play a major role in effector functions of cytotoxic T lymphocytes after adenovirus vector-mediated gene transfer.
    Chirmule N; Moscioni AD; Qian Y; Qian R; Chen Y; Wilson JM
    Hum Gene Ther; 1999 Jan; 10(2):259-69. PubMed ID: 10022550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoviral vector-mediated gene therapy in the mouse lung: no role of Fas-Fas ligand interactions for elimination of transgene expression in bronchioepithelial cells.
    Chirmule N; Moffett J; Dhagat P; Tazelaar J; Wilson JM
    Hum Gene Ther; 1999 Nov; 10(17):2839-46. PubMed ID: 10584929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-lasting adenovirus transgene expression in mice through neonatal intrathymic tolerance induction without the use of immunosuppression.
    DeMatteo RP; Chu G; Ahn M; Chang E; Barker CF; Markmann JF
    J Virol; 1997 Jul; 71(7):5330-5. PubMed ID: 9188602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a recombinant adenovirus vector encoding Fas ligand with a CRE/Loxp inducible system.
    Bilbao G; Zhang H; Contreras JL; Zhou T; Feng M; Saito I; Mountz JD; Curiel DT
    Transplant Proc; 1999; 31(1-2):792-3. PubMed ID: 10083340
    [No Abstract]   [Full Text] [Related]  

  • 7. On/off switching Fas-ligand gene expression in liver by Cre/Loxp adenovirus vector system.
    Fujino M; Li XK; Okuyama T; Funeshima N; Tamura A; Enosawa S; Kita Y; Amano T; Yamada M; Amemiya H; Suzuki S
    Transplant Proc; 1999; 31(1-2):753-4. PubMed ID: 10083322
    [No Abstract]   [Full Text] [Related]  

  • 8. Fulminant hepatitis by Fas-ligand expression in MRL-lpr/lpr mice grafted with Fas-positive livers and wild-type mice with Fas-mutant livers.
    Li XK; Fujino M; Sugioka A; Morita M; Okuyama T; Guo L; Funeshima N; Kimura H; Enosawa S; Amemiya H; Suzuki S
    Transplantation; 2001 Feb; 71(4):503-8. PubMed ID: 11258428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fas-mediated apoptosis is involved in the elimination of gene-transduced hepatocytes with E1/E3-deleted adenoviral vectors.
    Okuyama T; Li XK; Funeshima N; Fujino M; Sasaki K; Kita Y; Kosuga M; Takahashi M; Saito H; Suzuki S; Yamada M
    J Gastroenterol Hepatol; 1998 Sep; 13 Suppl():S113-8. PubMed ID: 9792044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways.
    Benihoud K; Bonardelle D; Bobé P; Kiger N
    Eur J Immunol; 1997 Feb; 27(2):415-20. PubMed ID: 9045912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunomodulatory procedure that stabilizes transgene expression and permits readministration of E1-deleted adenovirus vectors.
    Kuzmin AI; Galenko O; Eisensmith RC
    Mol Ther; 2001 Mar; 3(3):293-301. PubMed ID: 11273770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mature but not immature Fas ligand (CD95L)-transduced human monocyte-derived dendritic cells are protected from Fas-mediated apoptosis and can be used as killer APC.
    Hoves S; Krause SW; Halbritter D; Zhang HG; Mountz JD; Schölmerich J; Fleck M
    J Immunol; 2003 Jun; 170(11):5406-13. PubMed ID: 12759415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic T lymphocyte responses to proteins encoded by heterologous transgenes transferred in vivo by adenoviral vectors.
    Song W; Kong HL; Traktman P; Crystal RG
    Hum Gene Ther; 1997 Jul; 8(10):1207-17. PubMed ID: 9215738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local adenoviral expression of Fas ligand upregulates pro-inflammatory immune responses in the CNS.
    Regardsoe EL; McMenamin MM; Charlton HM; Wood MJ
    Gene Ther; 2004 Oct; 11(19):1462-74. PubMed ID: 15306838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient Fas-ligand gene expression in rodent liver after intravenous injection of a recombinant adenovirus by the use of a Cre-mediated switching system.
    Okuyama T; Fujino M; Li XK; Funeshima N; Kosuga M; Saito I; Suzuki S; Yamada M
    Gene Ther; 1998 Aug; 5(8):1047-53. PubMed ID: 10326027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.
    Kaplan JM; Yu Q; Piraino ST; Pennington SE; Shankara S; Woodworth LA; Roberts BL
    J Immunol; 1999 Jul; 163(2):699-707. PubMed ID: 10395660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement.
    Ji L; Bouvet M; Price RE; Roth JA; Fang B
    Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo analysis of adenovirus-specific cytotoxic T lymphocyte response in mice deficient in CD28, fas ligand, and perforin.
    Chen J; Hsu HC; Zajac AJ; Wu Q; Yang P; Xu X; McPherson SA; Li J; Curiel DT; Mountz JD
    Hum Gene Ther; 2006 Jun; 17(6):669-82. PubMed ID: 16776575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms.
    Kafrouni MI; Brown GR; Thiele DL
    J Immunol; 2001 Aug; 167(3):1566-74. PubMed ID: 11466378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity.
    Morelli AE; Larregina AT; Smith-Arica J; Dewey RA; Southgate TD; Ambar B; Fontana A; Castro MG; Lowenstein PR
    J Gen Virol; 1999 Mar; 80 ( Pt 3)():571-583. PubMed ID: 10091995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.